✨ Free AI Report
Arthrex, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Arthrex, Inc.
Company Research

Arthrex, Inc.: Business Overview, Financials & Competitive Analysis

Arthrex, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Market-leading private orthopedic medical device company with $3.2B revenue, strong innovation pipeline, and global distribution—positioned for continued growth in minimally invasive surgery. Arthrex generated annual revenue of $3.2 billion in 2026, reflecting strong market position and scale in the orthopedic surgical devices sector. The company's focus on minimally invasive technology.

What is Arthrex, Inc.'s industry? Arthrex, Inc. (arthrex.com) operates in Orthopedic Devices. AskCyborg classifies Arthrex, Inc. under Orthopedic Devices in its company registry.

Arthrex is a privately held company committed to delivering uncompromising quality to healthcare professionals through innovative orthopedic surgical solutions. The company addresses needs across anatomical regions in...

8/ 10Strong

Cyborg Score thesis

Market-leading private orthopedic medical device company with $3.2B revenue, strong innovation pipeline, and global...

Read the full analyst-debate transcript →
Industry Orthopedic Devices
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Arthrex, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Arthrex, Inc.

AskCyborg analysts argue the bull and bear cases for Arthrex, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Arthrex, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Arthrex, Inc. Overview

Pro stress-test →

Arthrex is a privately held company committed to delivering uncompromising quality to healthcare professionals through innovative orthopedic surgical solutions. The company addresses needs across anatomical regions including the shoulder, knee, elbow, hand and wrist, foot and ankle, and hip, offering solutions in orthobiologics and advanced imaging and resection technologies.

Strategic Profile

Pro stress-test →

Arthrex is a global medical device company and leader in new product development and medical education in orthopedics. The company competes against key players such as Zimmer Biomet, Smith + Nephew, and Johnson & Johnson Services Inc. in a $3.2 billion revenue business with significant global reach.

Competitive Landscape

Pro stress-test →

Arthrex competes against key players such as Zimmer Biomet, Smith + Nephew, and Johnson & Johnson Services Inc. The company differentiates through its focus on minimally invasive surgical technology, comprehensive anatomical coverage, and commitment to medical education and physician partnerships in orthopedics.

Industry Context

Arthrex, Inc. operates in Orthopedic Devices.

Key facts

Founded: 1980 · Headquarters: Naples, Florida, US · Employees: 9,034 · Revenue: $3.2 billion · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Arthrex, Inc..

  • Annual revenue reached $3.2 billion in 2026, reflecting robust demand across orthopedic markets
  • Global headquarters in Naples, FL with regional offices in Munich, Mexico City, and Singapore supporting worldwide market penetration
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Launched TightRope® SB implant for minimally invasive ACL reconstruction
  • April 2026Grew workforce to 9,034 employees supporting global operations
  • +1 moreTrack every material event for Arthrex, Inc. as it happens. Explore monitoring →
Get alerted when Arthrex, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Zimmer BiometGlobal leader in musculoskeletal healthcare and orthopedic devices→Smith + NephewLeading specialty surgical device manufacturer for orthopedics and trauma→Johnson & JohnsonDiversified healthcare conglomerate with orthopedic device portfolio→NuVasiveSurgical solutions for spine and orthopedic procedures→

Compare Arthrex, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Arthrex, Inc. operates in Orthopedic Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Orthopedic Devices research →
NEW · MCP server

Ask your AI assistant about Arthrex, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Arthrex, Inc. and its top competitor on Cyborg Score”
“What did Arthrex, Inc. do this quarter?”
“Is Arthrex, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Arthrex, Inc. do?+
Arthrex is a privately held company committed to delivering uncompromising quality to healthcare professionals through innovative orthopedic surgical solutions. The company addresses needs across anatomical regions in...
What is Arthrex, Inc.'s Cyborg Score?+
Arthrex, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Arthrex, Inc.'s main competitors?+
Named competitors include Zimmer Biomet, Smith + Nephew, Johnson & Johnson, NuVasive. The full competitive landscape is in the AskCyborg report.
How can I get the full Arthrex, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Arthrex, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Arthrex, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Orthopedic Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Johnson & Johnson